MKI67 and neoplasm: G1 remarkably decreased Ki-67 expression, representing tumor proliferation ability (36), whereas the observed effects could be attributed to the indicated signaling pathway inhibitors (Figures 6C, D), and these results corresponded with previous tumor volume studies.